Bortezomib biosimilar - Dr. Reddy's Laboratories
Latest Information Update: 01 Sep 2016
At a glance
- Originator Dr Reddys Laboratories
- Class Antineoplastics; Antirheumatics; Boronic acids; Pyrazines; Small molecules
- Mechanism of Action Apoptosis stimulants; Immunomodulators; Proteasome inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Suspended Multiple myeloma
Most Recent Events
- 31 Aug 2016 Suspended - Clinical-Phase-Unknown for Multiple myeloma (First-line therapy, Late-stage disease) in India (Injection)
- 20 May 2015 Clinical trials in Multiple myeloma (First-line therapy, Late-stage disease) in India (Injection)